AmpliPhi Biosciences Corp. (APHB) CEO Paul Grint on C3J Therapeutics Merger Conference Call (Transcript)

AmpliPhi Biosciences Corp. (APHB) AmpliPhi Biosciences and C3J Therapeutics Agree to Merge Conference Call January 14, 2018 4:30 PM ET Company Participants Robert Uhl - Westwicke Partners Paul Grint - Chief Executive Officer, AmpliPhi Biosciences Steve Martin - Chief Financial Officer, AmpliPhi Biosciences Todd Patrick - President and Chief Executive Officer, C3J Therapeutics Brian Varnum - Chief Development Officer, C3J Therapeutics Conference Call Participants Joe Pantginis - HC Wainwright Michael Higgins ...